LOGC
Bank of New York Mellon’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-10,930
| Closed | -$3K | – | 4606 |
|
2022
Q3 | $3K | Hold |
10,930
| – | – | ﹤0.01% | 4543 |
|
2022
Q2 | $4K | Hold |
10,930
| – | – | ﹤0.01% | 4575 |
|
2022
Q1 | $7K | Hold |
10,930
| – | – | ﹤0.01% | 4649 |
|
2021
Q4 | $25K | Hold |
10,930
| – | – | ﹤0.01% | 4573 |
|
2021
Q3 | $50K | Hold |
10,930
| – | – | ﹤0.01% | 4431 |
|
2021
Q2 | $49K | Sell |
10,930
-43,068
| -80% | -$193K | ﹤0.01% | 4323 |
|
2021
Q1 | $394K | Sell |
53,998
-1,829
| -3% | -$13.3K | ﹤0.01% | 3810 |
|
2020
Q4 | $427K | Buy |
55,827
+26,633
| +91% | +$204K | ﹤0.01% | 3692 |
|
2020
Q3 | $265K | Buy |
29,194
+239
| +0.8% | +$2.17K | ﹤0.01% | 3764 |
|
2020
Q2 | $245K | Buy |
28,955
+8,103
| +39% | +$68.6K | ﹤0.01% | 3745 |
|
2020
Q1 | $103K | Hold |
20,852
| – | – | ﹤0.01% | 3850 |
|
2019
Q4 | $151K | Hold |
20,852
| – | – | ﹤0.01% | 3961 |
|
2019
Q3 | $225K | Sell |
20,852
-1,887
| -8% | -$20.4K | ﹤0.01% | 3869 |
|
2019
Q2 | $295K | Sell |
22,739
-222
| -1% | -$2.88K | ﹤0.01% | 3808 |
|
2019
Q1 | $227K | Buy |
+22,961
| New | +$227K | ﹤0.01% | 3837 |
|